Kidney Disease Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

National Kidney Month 2026: Breakthrough Kidney Disease Therapies

The Glomerular Revolution: Understanding the New Wave of Breakthroughs in Rare Kidney Diseases

“It Takes 2” with Boehringer Ingelheim and Eli Lilly as They Spotlight Kidney Health

December 15, 2025

Voyxact Becomes First Biologic Approved for IgA Nephropathy as Competitors Advance

December 2, 2025

Exploring Polycystic Kidney Disease Clinical Trials and New Treatments

December 04, 2025

Redefining Autoimmune Kidney Disease Treatment Through Science-Led Innovation

August 26, 2025

Healthcare News

Travere Therapeutics Launches “Play It Forward” Campaign to Spotlight FSGS Rare Kidney Disease Community

Sibeprenlimab Shows 51% Reduction in Proteinuria in Pivotal IgAN Trial

World Lupus Day 2025: Emerging Pipeline Advances from Biopharma

Vanrafia (Atrasentan) Earns FDA Approval for IgAN, Achieved Proteinuria Reduction

Novartis’ Fabhalta (Iptacopan) Earns Third FDA Nod, This Time for C3G

Life Science News

FDA Cautions Hemodialysis Tubing Shortage Could Persist into Fall

Taking Charge on National Kidney Month 2025 and World Kidney Day 2025: Are Your Kidneys OK?

Maze Therapeutics Introduces IPO with Two CKD Candidates in Clinical Trials

February 4, 2025

FDA Approves New Use for Ozempic to Reduce the Risks of Kidney Disease

January 29, 2025

Clinical Trial News

Cenerimod Reduces SLE Disease Activity, Paves the Way for Phase III

December 30, 2024

Next Page »